Editorial Public Health Genomics 2014;17:125–126 DOI: 10.1159/000363559
Published online: June 13, 2014
Public Health Genomics Joins Forces with the Genomic Medicine Alliance George P. Patrinos a Angela Brand b a
Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece; b Institute for Public Health Genomics, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
Angela Brand
George P. Patrinos
The Genomic Medicine Alliance (GMA; www. genomicmedicinealliance.org) is an international scientific research network aiming to build/strengthen collaboration ties between academics, researchers, regulators, and the general public interested in all aspects of genomic medicine, focusing in particular on translating results from genomics research into genomic medicine and the clinical practice in general. Also, GMA aims to bridge genomics research between developed and developing
countries, by encouraging technology and knowledge transfer, providing training opportunities to researchers from developing countries, and by stimulating partnerships and consortia formation between GMA members from all over the world. In actual fact, several new international collaborations and regional consortia have already been developed from this initiative. The GMA research activities are multidisciplinary and revolve around six Working Groups in the fields of Phar-
© 2014 S. Karger AG, Basel 1662–4246/14/0173–0125$39.50/0 E-Mail [email protected] www.karger.com/phg
Prof. Dr. Angela Brand Institute for Public Health Genomics Faculty of Health, Medicine and Life Sciences, Maastricht University PO Box 616, NL–6200 MD Maastricht (The Netherlands) E-Mail a.brand @ maastrichtuniversity.nl
macogenomics, Genome Informatics, Public Health Genomics, Genethics and Economic Evaluation in Genomic Medicine. Scientific coordination is provided by the Scientific Advisory Committee, comprising 14 internationally renowned scientists in the field of genomics research. GMA membership is free-of-charge to encourage participation of researchers from developing and low-income countries and, at present, spans across 53 countries worldwide. We are pleased to announce that Public Health Genomics has recently become the official journal of the GMA. Together we announce the Public Health Genomics–Genomic Medicine Alliance Prize for early-stage researchers in an effort to incentivize young GMA mem-
126
Public Health Genomics 2014;17:125–126 DOI: 10.1159/000363559
bers to present their work at the international Golden Helix Symposia® meeting series. This annual prize will be presented for the first time at the 2014 Golden Helix Symposium to the best presentation of a young scientist. Lastly, the editorial team of Public Health Genomics is enriched with new members from the GMA Scientific Advisory Committee to contribute new perspectives to the journal’s aims and scope. This partnership is expected to be mutually beneficial to the GMA members, since it does not only offer unique privileges, discounts, and a prestigious forum of publication of their original research and opinion articles, but is also expected to expand the, already high, impact and readership of Public Health Genomics.
Patrinos /Brand
Copyright: S. Karger AG, Basel 2014. Reproduced with the permission of S. Karger AG, Basel. Further reproduction or distribution (electronic or otherwise) is prohibited without permission from the copyright holder.
Published online: June 13, 2014
Public Health Genomics Joins Forces with the Genomic Medicine Alliance George P. Patrinos a Angela Brand b a
Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece; b Institute for Public Health Genomics, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
Angela Brand
George P. Patrinos
The Genomic Medicine Alliance (GMA; www. genomicmedicinealliance.org) is an international scientific research network aiming to build/strengthen collaboration ties between academics, researchers, regulators, and the general public interested in all aspects of genomic medicine, focusing in particular on translating results from genomics research into genomic medicine and the clinical practice in general. Also, GMA aims to bridge genomics research between developed and developing
countries, by encouraging technology and knowledge transfer, providing training opportunities to researchers from developing countries, and by stimulating partnerships and consortia formation between GMA members from all over the world. In actual fact, several new international collaborations and regional consortia have already been developed from this initiative. The GMA research activities are multidisciplinary and revolve around six Working Groups in the fields of Phar-
© 2014 S. Karger AG, Basel 1662–4246/14/0173–0125$39.50/0 E-Mail [email protected] www.karger.com/phg
Prof. Dr. Angela Brand Institute for Public Health Genomics Faculty of Health, Medicine and Life Sciences, Maastricht University PO Box 616, NL–6200 MD Maastricht (The Netherlands) E-Mail a.brand @ maastrichtuniversity.nl
macogenomics, Genome Informatics, Public Health Genomics, Genethics and Economic Evaluation in Genomic Medicine. Scientific coordination is provided by the Scientific Advisory Committee, comprising 14 internationally renowned scientists in the field of genomics research. GMA membership is free-of-charge to encourage participation of researchers from developing and low-income countries and, at present, spans across 53 countries worldwide. We are pleased to announce that Public Health Genomics has recently become the official journal of the GMA. Together we announce the Public Health Genomics–Genomic Medicine Alliance Prize for early-stage researchers in an effort to incentivize young GMA mem-
126
Public Health Genomics 2014;17:125–126 DOI: 10.1159/000363559
bers to present their work at the international Golden Helix Symposia® meeting series. This annual prize will be presented for the first time at the 2014 Golden Helix Symposium to the best presentation of a young scientist. Lastly, the editorial team of Public Health Genomics is enriched with new members from the GMA Scientific Advisory Committee to contribute new perspectives to the journal’s aims and scope. This partnership is expected to be mutually beneficial to the GMA members, since it does not only offer unique privileges, discounts, and a prestigious forum of publication of their original research and opinion articles, but is also expected to expand the, already high, impact and readership of Public Health Genomics.
Patrinos /Brand
Copyright: S. Karger AG, Basel 2014. Reproduced with the permission of S. Karger AG, Basel. Further reproduction or distribution (electronic or otherwise) is prohibited without permission from the copyright holder.
